$XELB
XCel Brands, Inc.

2017 Q2 Form 10-Q Financial Statement

#000114420417042093 Filed on August 10, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q4 2016 Q2
Revenue $8.370M $6.900M $9.112M
YoY Change -8.14% -7.63% 44.15%
Cost Of Revenue $0.00 $36.00K
YoY Change -100.0% 2.86%
Gross Profit $8.370M $9.080M
YoY Change -7.82% 44.45%
Gross Profit Margin 100.0% 99.65%
Selling, General & Admin $1.134M $6.460M $2.020M
YoY Change -43.86% 15.36% -63.41%
% of Gross Profit 13.55% 22.25%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $390.0K $390.0K $360.0K
YoY Change 8.33% -9.3% 12.5%
% of Gross Profit 4.66% 3.96%
Operating Expenses $1.134M $6.850M $2.020M
YoY Change -43.86% 13.6% -65.41%
Operating Profit $1.118M $232.0K
YoY Change 381.9% -91.36%
Interest Expense -$350.0K -$420.0K -$530.0K
YoY Change -33.96% -2.33% 23.26%
% of Operating Profit -31.31% -228.45%
Other Income/Expense, Net
YoY Change
Pretax Income $770.0K $3.040M -$298.0K
YoY Change -358.39% 245.45% -113.24%
Income Tax $557.0K $320.0K -$208.0K
% Of Pretax Income 72.34% 10.53%
Net Earnings $213.0K $2.750M -$90.00K
YoY Change -336.67% 257.14% -104.27%
Net Earnings / Revenue 2.54% 39.86% -0.99%
Basic Earnings Per Share $0.01 $0.00
Diluted Earnings Per Share $0.01 $135.1K $0.00
COMMON SHARES
Basic Shares Outstanding 18.45M shares 18.67M shares
Diluted Shares Outstanding 18.81M shares 18.67M shares

Balance Sheet

Concept 2017 Q2 2016 Q4 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.600M $14.10M $13.50M
YoY Change -43.7% -16.57% 419.23%
Cash & Equivalents $7.621M $15.64M $13.47M
Short-Term Investments
Other Short-Term Assets $900.0K $800.0K $600.0K
YoY Change 50.0% 33.33% -57.14%
Inventory
Prepaid Expenses
Receivables $8.700M $7.000M $10.10M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $17.20M $21.90M $24.10M
YoY Change -28.63% -12.78% 127.36%
LONG-TERM ASSETS
Property, Plant & Equipment $2.500M $2.600M $2.400M
YoY Change 4.17% 198.51% 242.86%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $3.000M $3.000M $282.0K
YoY Change 963.83% 774.64% -89.15%
Total Long-Term Assets $128.6M $129.2M $128.3M
YoY Change 0.23% 1.72% 13.54%
TOTAL ASSETS
Total Short-Term Assets $17.20M $21.90M $24.10M
Total Long-Term Assets $128.6M $129.2M $128.3M
Total Assets $145.8M $151.1M $152.4M
YoY Change -4.33% -0.67% 23.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.100M $1.500M $3.800M
YoY Change -71.05% -54.55% 65.22%
Accrued Expenses $1.300M $2.200M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $4.000M $6.427M $8.100M
YoY Change -50.62% -27.93% -22.86%
Total Short-Term Liabilities $6.400M $10.40M $11.92M
YoY Change -46.3% -20.83% -10.38%
LONG-TERM LIABILITIES
Long-Term Debt $22.00M $25.50M $29.84M
YoY Change -26.28% -19.96% -8.18%
Other Long-Term Liabilities $2.500M $2.200M $1.800M
YoY Change 38.89% 633.33% 800.0%
Total Long-Term Liabilities $32.41M $34.58M $38.15M
YoY Change -15.07% -11.13% 16.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.400M $10.40M $11.92M
Total Long-Term Liabilities $32.41M $34.58M $38.15M
Total Liabilities $38.84M $44.95M $50.07M
YoY Change -22.44% -13.64% -7.27%
SHAREHOLDERS EQUITY
Retained Earnings $8.615M $8.801M $5.931M
YoY Change 45.25% 45.09%
Common Stock $98.37M $97.37M $96.40M
YoY Change 2.04% 3.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $107.0M $106.2M $102.3M
YoY Change
Total Liabilities & Shareholders Equity $145.8M $151.1M $152.4M
YoY Change -4.32% -0.66% 23.31%

Cashflow Statement

Concept 2017 Q2 2016 Q4 2016 Q2
OPERATING ACTIVITIES
Net Income $213.0K $2.750M -$90.00K
YoY Change -336.67% 257.14% -104.27%
Depreciation, Depletion And Amortization $390.0K $390.0K $360.0K
YoY Change 8.33% -9.3% 12.5%
Cash From Operating Activities $1.430M $1.150M $3.630M
YoY Change -60.61% -39.79% -1137.14%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K -$250.0K -$1.470M
YoY Change -99.32% -43.18% 7250.0%
Acquisitions
YoY Change
Other Investing Activities -$580.0K
YoY Change -152.25%
Cash From Investing Activities -$10.00K -$820.0K -$1.470M
YoY Change -99.32% -220.59% 2.8%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.010M -1.360M -870.0K
YoY Change 360.92% 65.85% -52.2%
NET CHANGE
Cash From Operating Activities 1.430M 1.150M 3.630M
Cash From Investing Activities -10.00K -820.0K -1.470M
Cash From Financing Activities -4.010M -1.360M -870.0K
Net Change In Cash -2.590M -1.030M 1.290M
YoY Change -300.78% -158.19% -135.83%
FREE CASH FLOW
Cash From Operating Activities $1.430M $1.150M $3.630M
Capital Expenditures -$10.00K -$250.0K -$1.470M
Free Cash Flow $1.440M $1.400M $5.100M
YoY Change -71.76% -40.43% -1645.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 us-gaap Liabilities
Liabilities
38836000 USD
CY2016Q4 us-gaap Liabilities
Liabilities
44946000 USD
CY2017Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q2 us-gaap Common Stock Value
CommonStockValue
18000 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
19000 USD
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
98354000 USD
CY2016Q4 us-gaap Stockholders Equity
StockholdersEquity
106174000 USD
CY2016Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
97354000 USD
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8615000 USD
CY2016Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
8801000 USD
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
106987000 USD
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
145823000 USD
CY2016Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
151120000 USD
CY2017Q2 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
2472000 USD
CY2016Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
2181000 USD
CY2017Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1509000 USD
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1509000 USD
CY2017Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
32405000 USD
CY2017Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1054000 USD
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1523000 USD
CY2017Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1261000 USD
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2185000 USD
CY2016Q2 xelb Salaries Benefits And Employment Taxes
SalariesBenefitsAndEmploymentTaxes
4217000 USD
CY2017Q2 xelb Salaries Benefits And Employment Taxes
SalariesBenefitsAndEmploymentTaxes
4360000 USD
CY2017Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
645000 USD
CY2016Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2020000 USD
CY2017Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1134000 USD
CY2016Q2 xelb Amortization And Depreciation
AmortizationAndDepreciation
359000 USD
CY2017Q2 xelb Amortization And Depreciation
AmortizationAndDepreciation
390000 USD
CY2017Q2 us-gaap Costs And Expenses
CostsAndExpenses
7252000 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
232000 USD
CY2016Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
352000 USD
CY2016Q2 us-gaap Other Financial Services Costs
OtherFinancialServicesCosts
178000 USD
CY2016Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
530000 USD
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-208000 USD
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
557000 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-90000 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
213000 USD
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
770000 USD
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-298000 USD
CY2017Q2 us-gaap Sales Revenue Net
SalesRevenueNet
8370000 USD
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
9112000 USD
us-gaap Net Income Loss
NetIncomeLoss
-135000 USD
us-gaap Net Income Loss
NetIncomeLoss
-186000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
785000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
784000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
94000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
99000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2665000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1806000 USD
xelb Amortization Of Seller Note Discount
AmortizationOfSellerNoteDiscount
158000 USD
xelb Amortization Of Seller Note Discount
AmortizationOfSellerNoteDiscount
19000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-259000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1013000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2484000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1779000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-558000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-161000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
875000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
290000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1718000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
140000 USD
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
67000 USD
CY2017Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-4236000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-158000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1718000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
20000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
806000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
302000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
69000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
5959000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
3000000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6506000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2989000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
449000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1394000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
118000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
144000 USD
us-gaap Interest Paid
InterestPaid
560000 USD
us-gaap Interest Paid
InterestPaid
677000 USD
xelb Payment Of Earnout Obligations
PaymentOfEarnoutObligations
0 USD
xelb Payment Of Earnout Obligations
PaymentOfEarnoutObligations
250000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
18000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13471000 USD
CY2016Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1509000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-6772000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-3601000 USD
CY2016Q2 us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
-36000 USD
CY2017Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
114909000 USD
CY2016Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
114891000 USD
CY2016Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-3671000 USD
CY2017Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
282000 USD
CY2017Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
429000 USD
CY2016Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
509000 USD
CY2017Q2 us-gaap Long Term Debt
LongTermDebt
26062000 USD
CY2016Q4 us-gaap Long Term Debt
LongTermDebt
31922000 USD
CY2017Q2 xelb Long Term Debt And Contingent Obligations Current
LongTermDebtAndContingentObligationsCurrent
4043000 USD
CY2016Q4 xelb Long Term Debt And Contingent Obligations Current
LongTermDebtAndContingentObligationsCurrent
6427000 USD
CY2017Q2 xelb Minimum Liquidity Covenants
MinimumLiquidityCovenants
3000000 USD
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2436000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
815000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
xelb Share Based Compensation Arrangement By Share Based Payment Award Option Exercises In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionExercisesInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
93000 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3158000 shares
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
811670 shares
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.98
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.62
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.66
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.01
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y4M17D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y7M10D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y6M14D
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.72 pure
CY2016Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.7 pure
us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.57 pure
xelb Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
0.31 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.22 pure
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.66 pure
us-gaap Royalty Expense
RoyaltyExpense
9000 USD
us-gaap Royalty Expense
RoyaltyExpense
62000 USD
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
50000 shares
CY2017Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
25000 shares
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q2 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
100000 USD
CY2016Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
0 USD
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2017Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18471001 shares
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
35000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
35000000 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18471001 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18644982 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18644982 shares
us-gaap Sales Revenue Net
SalesRevenueNet
16800000 USD
us-gaap Sales Revenue Net
SalesRevenueNet
17473000 USD
xelb Salaries Benefits And Employment Taxes
SalariesBenefitsAndEmploymentTaxes
8727000 USD
xelb Salaries Benefits And Employment Taxes
SalariesBenefitsAndEmploymentTaxes
8427000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1516000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1660000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2414000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3365000 USD
xelb Amortization And Depreciation
AmortizationAndDepreciation
784000 USD
xelb Amortization And Depreciation
AmortizationAndDepreciation
785000 USD
us-gaap Costs And Expenses
CostsAndExpenses
15247000 USD
us-gaap Costs And Expenses
CostsAndExpenses
16902000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1553000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
571000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
632000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
663000 USD
us-gaap Other Financial Services Costs
OtherFinancialServicesCosts
94000 USD
us-gaap Other Financial Services Costs
OtherFinancialServicesCosts
302000 USD
us-gaap Interest And Debt Expense
InterestAndDebtExpense
726000 USD
us-gaap Interest And Debt Expense
InterestAndDebtExpense
965000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
827000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-394000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1013000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-259000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18565198 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18671648 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18561453 shares
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18449210 shares
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18813044 shares
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18671648 shares
CY2016Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
282000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18561453 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18565198 shares
us-gaap Prior Period Reclassification Adjustment
PriorPeriodReclassificationAdjustment
-106000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
565000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
564000 USD
CY2017Q2 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.07 pure
CY2016Q2 xelb Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
0.29 pure
xelb Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
0.25 pure
us-gaap Long Term Debt Maturities Repayment Terms
LongTermDebtMaturitiesRepaymentTerms
the Company shall pay an early termination fee equal to the principal amount outstanding under the Term Loan on the date of prepayment, multiplied by: (i) two percent (2.00%) if the Xcel Term Loan is prepaid on or after the closing date and on or before the second anniversary of the closing date; or (ii) one percent (1.00%) if the Xcel Term Loan is prepaid after the second anniversary of the closing date and on or before the third anniversary of the closing date.
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.3369 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.3520 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0152 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0202 pure
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Business Exit Costs1
BusinessExitCosts1
0 USD
us-gaap Business Exit Costs1
BusinessExitCosts1
648000 USD
CY2017Q2 us-gaap Royalty Expense
RoyaltyExpense
0 USD
CY2016Q2 us-gaap Royalty Expense
RoyaltyExpense
28000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
79000 USD
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15636000 USD
CY2015Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17969000 USD
CY2017Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9130000 USD
CY2016Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14980000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
424000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2330000 USD
CY2017Q2 xelb Effective Income Tax Rate Reconciliation Permanent Differences Percent
EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent
0.31 pure

Files In Submission

Name View Source Status
0001144204-17-042093-index-headers.html Edgar Link pending
0001144204-17-042093-index.html Edgar Link pending
0001144204-17-042093.txt Edgar Link pending
0001144204-17-042093-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v471951_10q.htm Edgar Link pending
v471951_ex31-1.htm Edgar Link pending
v471951_ex31-2.htm Edgar Link pending
v471951_ex32-1.htm Edgar Link pending
v471951_ex32-2.htm Edgar Link pending
xelb-20170630.xml Edgar Link completed
xelb-20170630.xsd Edgar Link pending
xelb-20170630_cal.xml Edgar Link unprocessable
xelb-20170630_def.xml Edgar Link unprocessable
xelb-20170630_lab.xml Edgar Link unprocessable
xelb-20170630_pre.xml Edgar Link unprocessable